| Light Chain Deposition Disease studied in …STUDIED_INderived11 of 11show fewer |
|---|
| → studied in | NCT05283993recruiting A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01169337Phase 3 · active not recruiting Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03820817Phase 1 · completed Rifaximin in Patients With Monoclonal Gammopathy · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03717844recruiting Registry for Adults With Plasma Cell Disorders (PCD's) · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520767Phase 2 · completed Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01728259Phase 1 · terminated First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01849783Phase 2 · completed Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01078454Phase 3 · completed Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01383759NA · completed Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01533194Phase 1 · completed Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 11 trials mapped (3 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |